Clinical Trial Update: Mucopolysaccharidosis VII Disease Monitoring Program

View source ↗

Summary

Ultragenyx Pharmaceutical is running a disease monitoring program for Mucopolysaccharidosis VII that is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Vii

Snippet

Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Mucopolysaccharidosis VII, MPS VII | Status: RECRUITING